- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-29-0022714

Maxlive Pharmaceuticals Private Limited
About Maxlive Pharmaceuticals Private Limited
Data last updated:
Maxlive Pharmaceuticals Private Limited is a private limited company based in Sahibabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC048133. Its GSTIN is 09AAHCM6935E1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Manoj Kumar and Ankur Vashishtha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. II – 7/6 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.38 Cr, a growth of 114% compared to the previous year. For the same year it recorded a net loss of ₹3.03 Lakh (net margin -0.4%) and EBITDA of ₹30.84 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹12.59 Cr and satisfied charges of ₹80 Lakh on record.
Maxlive Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0022714). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Maxlive Pharmaceuticals
Contact details
Maxlive Pharmaceuticals Private Limited's registered office is in Sahibabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. II – 7/6 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxlive Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxlive Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maxlive Pharmaceuticals Private Limited, buy the company report.
Financials of Maxlive Pharmaceuticals Private Limited
FY 2025 filings availableMaxlive Pharmaceuticals Private Limited reported revenue of ₹7.38 Cr (up 114% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 114% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxlive Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maxlive Pharmaceuticals Private Limited
Maxlive Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Also directs: MVP Prospera LLP | Director | 29 Dec 2011 | 14 Years 10 Months | Current |
| Ankur Vashishtha | Director | 03 Nov 2018 | 8 Years 0 Months | Current |
Peer comparison
Maxlive Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vyonics Healthcare India Private Limited | ₹7.39 Cr (FY 2025) | 4.0% | Delhi, India | |||
| Everva Lifecare Private Limited | ₹7.39 Cr (FY 2025) | 30.0% | Panchkula, Haryana, India | |||
| Navodaya Pharmaceuticals Private Limited | ₹7.38 Cr (FY 2024) | -19.0% | Noida, Uttar Pradesh, India | |||
| Vayuputra Marketing Private Limited | ₹7.38 Cr (FY 2016) | -7.0% | Tamil Nadu, India | |||
| Maxlive Pharmaceuticals Private Limitedthis company | ₹7.38 Cr (FY 2025) | -₹3.03 Lakh | -0.4% | 114.0% | Sahibabad, Uttar Pradesh, India | |
| Optho Pharma Private Limited | ₹7.37 Cr (FY 2024) | -9.0% | Allahabad, Uttar Pradesh, India | |||
| Ravenmac Pharmaceuticals Private Limited | ₹7.34 Cr (FY 2025) | 17.0% | Amritsar, Punjab, India |
To see the full peer comparison of Maxlive Pharmaceuticals Private Limited, buy the company report.
Auditor
Maxlive Pharmaceuticals Private Limited is audited by Praveen Amar & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Praveen Amar & CO. | FY 2023 | 041096N |
Shareholding
The shareholding of Maxlive Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxlive Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101177118 | Others | ₹1.78 Cr | Open | |
| 19 Oct 2024 | 100988618 | Others | ₹4.22 Cr | Open | |
| 15 Mar 2024 | 100900510 | Others | ₹10.08 Lakh | Open | |
| 14 Jun 2023 | 100735788 | Others | ₹3 Cr | Open | |
| 06 Oct 2020 | 100384396 | Hdfc Bank Limited | ₹3 Cr | Open |
To see the full charge records of Maxlive Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Maxlive Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxlive Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxlive Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCM6935E1Z9 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxlive Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maxlive Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Ankur Vashishtha ceased to be Additional Director on 30 Sep 2019.
4 earlier events are in the company report.
Frequently asked questions
Maxlive Pharmaceuticals is an active private limited company based in Sahibabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2011 (15+ years old) and is registered under CIN U24233UP2011PTC048133.
Maxlive Pharmaceuticals has 2 current directors:
- Manoj Kumar - Director
- Ankur Vashishtha - Director
The latest financial statements of Maxlive Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxlive Pharmaceuticals is 09AAHCM6935E1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxlive Pharmaceuticals is U24233UP2011PTC048133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxlive Pharmaceuticals was incorporated on 29 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Maxlive Pharmaceuticals by revenue are Vyonics Healthcare India Private Limited, Everva Lifecare Private Limited, Navodaya Pharmaceuticals Private Limited, Vayuputra Marketing Private Limited, Optho Pharma Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ankur Vashishtha ceased to be Additional Director on 30 Sep 2019. Amit Singh ceased to be Director on 03 Nov 2018. Ankur Vashishtha was appointed as Director on 03 Nov 2018. Maxlive Pharmaceuticals has 4 board changes on record in total.
Yes, Maxlive Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0022714).
The registered office of Maxlive Pharmaceuticals is at Shop No. II – 76 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005.
Maxlive Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

